WHO ICTRP trial
Effects of Donepezil or Rivastigmine in Patients with idiopathic REM Sleep…
KCT0004317 · Clinical Research Information Service (CRIS) · Not Recruiting
Key facts
| Trial ID | KCT0004317 |
|---|---|
| Public title | Effects of Donepezil or Rivastigmine in Patients with idiopathic REM Sleep Behavior Disorder Patients |
| Scientific title | Effects of Donepezil or Rivastigmine in Patients with idiopathic REM Sleep Behavior Disorder Patients |
| Primary sponsor | Keimyung University Dongsan Medical Center |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Not Recruiting |
| Study type | Interventional Study |
| Phase | Not applicable |
| Countries | Korea, Republic of |
| Conditions | Diseases of the nervous system |
| Interventions | Drug : product name: Aricept, main ingredient name: Donepezil, dose: 5mg, Dosage form: film coating, pathway: oral, Period: 5 years product name: Exelon, main ingredient name: Rivastigmine, dose:1.5mg, Dosage form: hard capsule, pathway… |
| Registration date | Oct 15, 2019 |
| Target size | 100 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: